Manufacturing and Production

Showing 15 posts of 5874 posts found.

PL BioScience appoints Maik Jornitz to Board of Directors

June 24, 2026 Manufacturing and Production PL Bioscience

PL BioScience has announced the appointment of Maik Jornitz to its board of directors, effective immediately. Jornitz brings technical expertise, …

Axplora consolidates liver disease API manufacturing in India

June 23, 2026 Manufacturing and Production Axplora

Axplora has announced the consolidation of ursodeoxycholic acid (UDCA) manufacturing at its Vizag facility in India as part of a …

Vetter begins construction of new injectable medicines facility

May 20, 2026 Manufacturing and Production Vetter

Vetter, a contract development and manufacturing organisation (CDMO), has begun construction of a new pharmaceutical manufacturing site in Saarlouis, Germany, …

Celtic Renewables receives £7m to develop bio-based solvents

May 14, 2026 Manufacturing and Production Celtic Renewables

Scottish green chemicals company Celtic Renewables is part of a consortium that has secured £7m in funding to support development …

Shilpa Medicare signs manufacturing deal with NXI Therapeutics

May 12, 2026 Manufacturing and Production Shilpa Medicare

Shilpa Medicare has entered into a long-term development and manufacturing agreement with Swiss biotech company NXI Therapeutics focused on an …

Practical AI toolkit launched to help manufacturers cut through complexity

May 6, 2026 Manufacturing and Production AI, Made Smarter

A new guide from Made Smarter is helping manufacturers cut through the noise around AI and focus on what actually …

BioPhorum acquires PharmaX Solutions

May 5, 2026 Manufacturing and Production BioPhorum, PharmaX Solutions

BioPhorum has acquired PharmaX Solutions, a consultancy specialising in digital transformation and end-to-end digital manufacturing solutions across pharmaceutical manufacturing and …

Trelleborg to take part in Medtec Japan 2026

April 8, 2026 Manufacturing and Production

Trelleborg Medical Solutions will showcase its latest engineered polymer solutions for demanding medical, biotech and pharmaceutical applications at Medtec Japan …

Naobios partners with SGS to manufacture RSV challenge agent

March 19, 2026 Manufacturing and Production Naobios, RSV, SGS

Contract Development and Manufacturing Organisation (CDMO) Naobios has partnered with SGS, a testing, inspection and certification company, to manufacture a …

Canada awards CSL Seqirus with influenza pandemic vaccine contract

March 17, 2026 Manufacturing and Production CSL Seqirus, Canada, Vaccine

CSL Seqirus has been awarded a contract committing it to manufacturing and delivering influenza vaccines to support the Public Health …

Coriolis Pharma opens new US headquarter and laboratory

March 16, 2026 Manufacturing and Production Coriolis Pharma, US, development

Coriolis Pharma has opened a new US headquarter and laboratory at the Alexandria Center for Advanced Technologies (ACAT) in North …

Thermo Fisher opens new distribution centre in Ireland

March 12, 2026 Warehousing & distribution Ireland, Thermo Fisher Scientific, distribution

Thermo Fisher Scientific has announced the opening of a new 70,000sqft distribution centre in Bracetown, County Meath, Ireland, expanding its …

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026 Manufacturing and Production BioDuro, Cenra API Solutions, manufacturing

BioDuro, a Contract Research, Development and Manufacturing Organisation (CRDMO), has established a joint venture with Cenra API Solutions, also known …

ESTEVE CDMO commences $15.5m expansion of US facility

March 6, 2026 Manufacturing and Production ESTEVE, US, expansion

ESTEVE CDMO, a global Contract Development and Manufacturing Organization (CDMO) specialising in small molecule active pharmaceutical ingredients (APIs) and pharmaceutical intermediates, …

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026 Manufacturing and Production Gedeon Richter UK, Neurology

Gedeon Richter UK has announced its acquisition of full marketing and distribution rights to Reagila (cariprazine), a schizophrenia treatment, from …
The Gateway to Local Adoption Series

Latest content